127 related articles for article (PubMed ID: 15480036)
1. Comparison of test-injection method and fixed-time method for depiction of hepatocellular carcinoma using dynamic steady-state free precession magnetic resonance imaging.
Shinozaki K; Yoshimitsu K; Irie H; Aibe H; Tajima T; Nishie A; Nakayama T; Kakihara D; Shimada M; Honda H
J Comput Assist Tomogr; 2004; 28(5):628-34. PubMed ID: 15480036
[TBL] [Abstract][Full Text] [Related]
2. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
[TBL] [Abstract][Full Text] [Related]
4. Optimal multi-phase three-dimensional fast imaging with steady-state free precession dynamic MRI and its clinical application to the diagnosis of hepatocellular carcinoma.
Shinozaki K; Honda H; Yoshimitsu K; Taguchi K; Kuroiwa T; Irie H; Aibe H; Nishie A; Nakayama T; Shimada M; Masuda K
Radiat Med; 2002; 20(3):111-9. PubMed ID: 12126083
[TBL] [Abstract][Full Text] [Related]
5. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
Kim YK; Kwak HS; Han YM; Kim CS
J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
[TBL] [Abstract][Full Text] [Related]
7. Ring-Like Enhancement of Hepatocellular Carcinoma in Gadoxetic Acid-Enhanced Multiphasic Hepatic Arterial Phase Imaging With Differential Subsampling With Cartesian Ordering.
Ichikawa S; Motosugi U; Oishi N; Shimizu T; Wakayama T; Enomoto N; Matsuda M; Onishi H
Invest Radiol; 2018 Apr; 53(4):191-199. PubMed ID: 29084013
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
9. Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging.
Park Y; Choi D; Kim SH; Kim SH; Kim MJ; Lee J; Lim JH; Lee WJ; Lim HK
Eur J Radiol; 2006 Sep; 59(3):424-31. PubMed ID: 16920312
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of optimal scan delay for gadoxetate disodium-enhanced hepatic arterial phase MRI using MR fluoroscopic triggering and slow injection technique.
Goshima S; Kanematsu M; Kondo H; Watanabe H; Kawada H; Moriyama N; Bae KT
AJR Am J Roentgenol; 2013 Sep; 201(3):578-82. PubMed ID: 23971449
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT.
Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Kumano S; Okada A; Sugiura T; Nakamura H
AJR Am J Roentgenol; 2003 Feb; 180(2):455-60. PubMed ID: 12540451
[TBL] [Abstract][Full Text] [Related]
12. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
[TBL] [Abstract][Full Text] [Related]
13. Helical CT during arterial portography and hepatic arteriography for detecting hypervascular hepatocellular carcinoma.
Murakami T; Oi H; Hori M; Kim T; Takahashi S; Tomoda K; Narumi Y; Nakamura H
AJR Am J Roentgenol; 1997 Jul; 169(1):131-5. PubMed ID: 9207512
[TBL] [Abstract][Full Text] [Related]
14. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
[TBL] [Abstract][Full Text] [Related]
15. Clinical Indication for Computed Tomography During Hepatic Arteriography (CTHA) in Addition to Dynamic CT Studies to Identify Hypervascularity of Hepatocellular Carcinoma.
Fuji T; Nakamura Y; Fukumoto W; Kajiwara K; Chosa K; Tani C; Matsubara Y; Terada H; Honda Y; Arihiro K; Iida M; Baba Y; Awai K
Cardiovasc Intervent Radiol; 2018 Apr; 41(4):618-627. PubMed ID: 29101449
[TBL] [Abstract][Full Text] [Related]
16. Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography.
Pugacheva O; Matsui O; Kozaka K; Minami T; Ryu Y; Koda W; Kobayashi S; Gabata T
Eur J Radiol; 2011 Dec; 80(3):e201-6. PubMed ID: 20855175
[TBL] [Abstract][Full Text] [Related]
17. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma.
Kanematsu M; Goshima S; Kondo H; Nishibori H; Kato H; Yokoyama R; Miyoshi T; Hoshi H; Onozuka M; Moriyama N
J Comput Assist Tomogr; 2005; 29(2):195-201. PubMed ID: 15772536
[TBL] [Abstract][Full Text] [Related]
18. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.
Kato H; Kanematsu M; Kondo H; Goshima S; Matsuo M; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Jan; 19(1):76-81. PubMed ID: 14696223
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of hypervascular liver tumors: timing optimization during the arterial phase.
Van Beers BE; Materne R; Lacrosse M; Jamart J; Smith AM; Horsmans Y; Gigot JF; Gilon R; Pringot J
J Magn Reson Imaging; 1999 Apr; 9(4):562-7. PubMed ID: 10232515
[TBL] [Abstract][Full Text] [Related]
20. Value of three-dimensional spiral CT hepatic angiography.
Kanematsu M; Imaeda T; Mizuno S; Yamawaki Y; Sone Y; Iida T; Kato M; Yokoyama R
AJR Am J Roentgenol; 1996 Mar; 166(3):585-91. PubMed ID: 8623632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
